Sino Biopharmaceutical Limited (SBHMY)
USD 8.34
(0.0%)
USD 8.34
(0.0%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 6.97 Billion CNY | -18.48% |
| 2022 | 6.69 Billion CNY | -61.03% |
| 2021 | 19.87 Billion CNY | 203.41% |
| 2020 | 6.54 Billion CNY | -10.05% |
| 2019 | 7.36 Billion CNY | 18.29% |
| 2018 | 6.14 Billion CNY | 36.12% |
| 2017 | 4.61 Billion CNY | 19.45% |
| 2016 | 3.59 Billion CNY | 17.45% |
| 2015 | 3.24 Billion CNY | 31.63% |
| 2014 | 2.48 Billion CNY | 34.73% |
| 2013 | 1.84 Billion CNY | 14.73% |
| 2012 | 1.58 Billion CNY | 71.09% |
| 2011 | 925.05 Million CNY | -7.93% |
| 2010 | 1 Billion CNY | 32.31% |
| 2009 | 759.39 Million CNY | 32.49% |
| 2008 | 573.15 Million CNY | 63.67% |
| 2007 | 350.22 Million CNY | 52.3% |
| 2006 | 229.93 Million CNY | 21.14% |
| 2005 | 189.8 Million CNY | -38.13% |
| 2004 | 306.79 Million CNY | 56.5% |
| 2003 | 196.03 Million CNY | 22.81% |
| 2002 | 159.62 Million CNY | 25.8% |
| 2001 | 140.76 Million CNY | 35.71% |
| 2000 | 93.49 Million CNY | 34.84% |
| 1999 | 69.34 Million CNY | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q2 | 570.08 Million USD | 0.0% |
| 2023 Q1 | 1.86 Billion USD | 267.05% |
| 2023 FY | - CNY | -18.48% |
| 2023 Q3 | - USD | -100.0% |
| 2023 Q4 | 401.29 Million USD | 0.0% |
| 2023 Q2 | 558.66 Million USD | -70.1% |
| 2022 Q4 | 509.02 Million USD | -68.31% |
| 2022 Q1 | 1.76 Billion CNY | 74.0% |
| 2022 Q2 | 1.76 Billion CNY | 0.0% |
| 2022 FY | - CNY | -61.03% |
| 2022 Q3 | 1.6 Billion USD | -9.19% |
| 2021 Q2 | 8.16 Billion CNY | 183.77% |
| 2021 Q4 | 1.01 Billion CNY | 0.0% |
| 2021 Q3 | 1.01 Billion CNY | -87.55% |
| 2021 FY | - CNY | 203.41% |
| 2021 Q1 | 2.87 Billion CNY | 214.65% |
| 2020 Q3 | 1.24 Billion CNY | -18.45% |
| 2020 FY | - CNY | -10.05% |
| 2020 Q1 | 1.19 Billion CNY | -2.17% |
| 2020 Q2 | 1.53 Billion CNY | 28.08% |
| 2020 Q4 | 914.5 Million CNY | -26.74% |
| 2019 Q1 | 1.25 Billion CNY | 90.19% |
| 2019 FY | - CNY | 18.29% |
| 2019 Q4 | 1.22 Billion CNY | -35.15% |
| 2019 Q3 | 1.88 Billion CNY | 29.66% |
| 2019 Q2 | 1.45 Billion CNY | 16.17% |
| 2018 FY | - CNY | 36.12% |
| 2018 Q1 | 1.03 Billion CNY | -18.09% |
| 2018 Q2 | 1.31 Billion CNY | 27.41% |
| 2018 Q3 | 1.96 Billion CNY | 48.68% |
| 2018 Q4 | 657.48 Million CNY | -66.48% |
| 2017 Q4 | 1.26 Billion CNY | -1.71% |
| 2017 Q3 | 1.28 Billion CNY | 44.44% |
| 2017 Q2 | 890.28 Million CNY | 21.26% |
| 2017 Q1 | 734.19 Million CNY | -22.99% |
| 2017 FY | - CNY | 19.45% |
| 2016 Q3 | 1.07 Billion CNY | 32.01% |
| 2016 Q1 | 587.02 Million CNY | -25.36% |
| 2016 Q4 | 953.38 Million CNY | -11.28% |
| 2016 FY | - CNY | 17.45% |
| 2016 Q2 | 814.07 Million CNY | 38.68% |
| 2015 Q2 | 708.32 Million CNY | 40.13% |
| 2015 FY | - CNY | 31.63% |
| 2015 Q1 | 505.46 Million CNY | -17.25% |
| 2015 Q4 | 786.45 Million CNY | -21.4% |
| 2015 Q3 | 1 Billion CNY | 41.26% |
| 2014 Q4 | 610.84 Million CNY | -18.15% |
| 2014 Q2 | 497.31 Million CNY | 18.4% |
| 2014 Q1 | 420.01 Million CNY | -8.35% |
| 2014 FY | - CNY | 34.73% |
| 2014 Q3 | 746.25 Million CNY | 50.06% |
| 2013 Q1 | 340.5 Million CNY | -15.82% |
| 2013 Q2 | 340.47 Million CNY | -0.01% |
| 2013 Q3 | 532.17 Million CNY | 56.31% |
| 2013 Q4 | 458.28 Million CNY | -13.88% |
| 2013 FY | - CNY | 14.73% |
| 2012 Q1 | 287.18 Million CNY | 12.48% |
| 2012 Q4 | 404.5 Million CNY | -7.26% |
| 2012 Q3 | 436.14 Million CNY | 36.13% |
| 2012 Q2 | 320.38 Million CNY | 11.56% |
| 2012 FY | - CNY | 71.09% |
| 2011 Q2 | 198.11 Million CNY | 4.63% |
| 2011 Q1 | 189.34 Million CNY | 0.0% |
| 2011 FY | - CNY | -7.93% |
| 2011 Q3 | 172.24 Million CNY | -13.06% |
| 2011 Q4 | 255.32 Million CNY | 48.24% |
| 2010 Q2 | 174.99 Million CNY | 1.85% |
| 2010 Q1 | 171.81 Million CNY | 0.0% |
| 2010 FY | - CNY | 32.31% |
| 2009 FY | - CNY | 32.49% |
| 2008 FY | - CNY | 63.67% |
| 2007 FY | - CNY | 52.3% |
| 2006 FY | - CNY | 21.14% |
| 2005 FY | - CNY | -38.13% |
| 2004 FY | - CNY | 56.5% |
| 2003 FY | - CNY | 22.81% |
| 2002 FY | - CNY | 25.8% |
| 2001 FY | - CNY | 35.71% |
| 2000 FY | - CNY | 34.84% |
| 1999 FY | - CNY | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| RegeneRx Biopharmaceuticals, Inc. | -1.4 Million USD | 497987.514% |
| CSL Limited | 4.78 Billion USD | -45.739% |
| Eiger BioPharmaceuticals, Inc. | -71.03 Million USD | 9925.197% |
| Nanobac Pharmaceuticals, Incorporated | -5.92 Million USD | 117818.572% |
| Institute of Biomedical Research Corp. | -239.15 Thousand USD | 2918530.692% |
| Evofem Biosciences, Inc. | -17.37 Million USD | 40280.927% |
| Santhera Pharmaceuticals Holding AG | 94.03 Million USD | -7321.912% |
| Propanc Biopharma, Inc. | -1.53 Million USD | 454475.284% |
| Mesoblast Limited | -62.38 Million USD | 11286.818% |
| Marizyme, Inc. | -34.28 Million USD | 20459.182% |
| Genus plc | 73.7 Million USD | -9370.05% |
| VioQuest Pharmaceuticals, Inc. | -6.61 Million USD | 105664.684% |
| CNBX Pharmaceuticals Inc. | -3.54 Million USD | 196869.973% |
| Nymox Pharmaceutical Corporation | -8.77 Million USD | 79664.831% |
| ContraFect Corporation | -64.99 Million USD | 10837.745% |
| PsyBio Therapeutics Corp. | -4.52 Million USD | 154300.758% |
| Sienna Biopharmaceuticals, Inc. | - USD | -Infinity% |
| IMV Inc. | -35.52 Million USD | 19747.41% |
| AXIM Biotechnologies, Inc. | -2.32 Million USD | 300442.841% |
| MultiCell Technologies, Inc. | -518.04 Thousand USD | 1347360.089% |
| Accustem Sciences Inc. | -3.74 Million USD | 186395.954% |
| RVL Pharmaceuticals plc | -48.22 Million USD | 14572.032% |
| EV Biologics, Inc. | -1.26 Million USD | 550905.046% |
| Q BioMed Inc. | -617.62 Thousand USD | 1130137.336% |
| Emmaus Life Sciences, Inc. | 3.57 Million USD | -195292.693% |
| Mosaic ImmunoEngineering Inc. | -2.28 Million USD | 305613.706% |
| Biomind Labs Inc. | -1.03 Million USD | 674734.744% |
| Oncotelic Therapeutics, Inc. | -7.16 Million USD | 97560.676% |
| Skye Bioscience, Inc. | -13.54 Million USD | 51618.001% |
| SQZ Biotechnologies Company | -64.14 Million USD | 10981.382% |
| THC Farmaceuticals, Inc. | -25 Thousand USD | 27917808.0% |
| Arch Therapeutics, Inc. | -3.88 Million USD | 179782.081% |
| Intellipharmaceutics International Inc. | -2.64 Million USD | 264027.557% |
| Acro Biomedical Co., Ltd. | -15.86 Million USD | 44079.475% |
| Neon Bloom, Inc. | -632.4 Thousand USD | 1103730.737% |
| TetraLogic Pharmaceuticals Corporation | - USD | -Infinity% |
| Pharming Group N.V. | 9.87 Million USD | -70563.43% |
| Therapeutic Solutions International, Inc. | -1.48 Million USD | 469332.936% |
| Curative Biotechnology, Inc. | -2.5 Million USD | 279058.154% |
| GB Sciences, Inc. | -1.41 Million USD | 491648.752% |
| Alpha Cognition Inc. | -9.7 Million USD | 72011.332% |
| argenx SE | -216.02 Million USD | 3330.871% |
| HST Global, Inc. | -5303.00 USD | 131612904.073% |
| Halberd Corporation | -74.27 Thousand USD | 9396331.775% |
| Enzolytics Inc. | -2.12 Million USD | 329003.469% |
| Resverlogix Corp. | -11.74 Million USD | 59539.848% |
| Arno Therapeutics, Inc. | - USD | -Infinity% |
| Nuo Therapeutics, Inc. | -3.06 Million USD | 227961.265% |
| MetaStat, Inc. | - USD | -Infinity% |
| Northwest Biotherapeutics, Inc. | -55.33 Million USD | 12712.131% |
| American Oriental Bioengineering, Inc. | -39.63 Million USD | 17708.426% |
| Enzon Pharmaceuticals, Inc. | 1.21 Million USD | -573394.412% |
| Provectus Biopharmaceuticals, Inc. | -2.89 Million USD | 241408.449% |
| Endonovo Therapeutics, Inc. | 8.85 Million USD | -78729.725% |
| GlobeStar Therapeutics Corporation | 6724.00 USD | -103798635.872% |
| RespireRx Pharmaceuticals Inc. | -1.49 Million USD | 465734.736% |
| GeneThera, Inc. | - USD | -Infinity% |
| Inhibitor Therapeutics, Inc. | 378.84 Thousand USD | -1842195.773% |
| AVAX Technologies, Inc. | -6.11 Million USD | 114280.184% |
| ONE Bio Corp. | 13.61 Million USD | -51170.142% |
| Zenith Capital Corp. | -8.6 Million USD | 81199.547% |
| Genscript Biotech Corporation | -248.71 Million USD | 2906.144% |
| Ember Therapeutics, Inc. | -17.42 Thousand USD | 40063397.17% |
| Anthera Pharmaceuticals, Inc. | - USD | -Infinity% |
| Sigyn Therapeutics, Inc. | -2.44 Million USD | 285386.665% |
| WPD Pharmaceuticals Inc. | -176.02 Thousand USD | 3965134.726% |
| Cotinga Pharmaceuticals Inc. | -1.92 Million USD | 363439.426% |
| Wesana Health Holdings Inc. | -2.05 Million USD | 339401.264% |
| Agentix Corp. | -1.37 Million USD | 508895.077% |
| Adynxx, Inc. | - USD | -Infinity% |
| Kadimastem Ltd | -2.62 Million USD | 266045.646% |
| Helix BioMedix, Inc. | -1.04 Million USD | 667150.268% |
| VitaSpring Biomedical Co. Ltd. | - USD | -Infinity% |
| Capstone Therapeutics Corp. | -1.74 Million USD | 398924.628% |
| BioStem Technologies, Inc. | -7.55 Million USD | 92498.134% |
| Oncology Pharma Inc. | - USD | -Infinity% |
| Reve Technologies, Inc. | -181.08 Thousand USD | 3854263.169% |
| Burzynski Research Institute, Inc. | - USD | -Infinity% |
| LadRx Corporation | 412.28 Thousand USD | -1692772.857% |
| Cell Source, Inc. | -4.27 Million USD | 163455.987% |
| ProtoKinetix, Incorporated | -367.22 Thousand USD | 1900706.719% |
| Regen BioPharma, Inc. | 1.46 Million USD | -476000.715% |
| Regen BioPharma, Inc. | -936.94 Thousand USD | 745010.022% |
| NovAccess Global Inc. | -1.03 Million USD | 674573.061% |
| Affymax, Inc. | -14.29 Million USD | 48924.257% |
| Itoco Inc. | -1.86 Million USD | 373532.085% |
| Rasna Therapeutics, Inc. | -379.62 Thousand USD | 1838629.846% |
| Pathfinder Cell Therapy, Inc. | -1.11 Million USD | 625496.685% |
| CytoDyn Inc. | -18.02 Million USD | 38812.225% |
| Claritas Pharmaceuticals, Inc. | - USD | -Infinity% |
| NDT Pharmaceuticals Inc. | -79.02 Thousand USD | 8831575.787% |
| NanoSphere Health Sciences Inc. | -12.22 Thousand USD | 57072853.291% |
| Qrons Inc. | -40.08 Thousand USD | 17413405.556% |
| Alseres Pharmaceuticals, Inc. | -485.67 Thousand USD | 1437148.209% |
| SYBLEU INC | -141.57 Thousand USD | 4930083.542% |
| Advanced Proteome Therapeutics Corporation | - USD | -Infinity% |
| Nascent Biotech, Inc. | 527.43 Thousand USD | -1323182.199% |
| Rebus Holdings, Inc. | -951 Thousand USD | 734003.996% |
| ImmunoCellular Therapeutics, Ltd. | -1.06 Million USD | 657290.328% |
| Mobile Lads Corp. | -2.24 Million USD | 311520.43% |
| International Stem Cell Corporation | 202 Thousand USD | -3455061.881% |
| Bioxytran, Inc. | -3.82 Million USD | 182800.482% |
| GlobeImmune, Inc. | - USD | -Infinity% |
| Predictive Technology Group, Inc. | - USD | -Infinity% |
| ProText Mobility, Inc. | -52.64 Thousand USD | 13258889.894% |
| Cardax, Inc. | - USD | -Infinity% |
| VG Life Sciences Inc. | -2.46 Million USD | 283593.898% |
| Kaleido Biosciences, Inc. | - USD | -Infinity% |
| Advaxis, Inc. | -35.86 Million USD | 19558.103% |
| Adhera Therapeutics, Inc. | - USD | -Infinity% |
| RenovaCare, Inc. | - USD | -Infinity% |
| Regnum Corp. | -45 Thousand USD | 15509937.778% |
| Innovation Pharmaceuticals Inc. | -2.73 Million USD | 255009.679% |
| Neutra Corp. | -181.24 Thousand USD | 3850882.082% |
| Windtree Therapeutics, Inc. | -20.15 Million USD | 34721.891% |
| PureTech Health plc | -11.62 Million USD | 60127.754% |
| Coeptis Therapeutics, Inc. | -20.15 Million USD | 34724.265% |
| IXICO plc | -707 Thousand USD | 987289.109% |
| IntelGenx Technologies Corp. | -7.68 Million USD | 90918.829% |
| Gelesis Holdings, Inc. | -48.34 Million USD | 14536.41% |
| CSL Limited | 4.73 Billion USD | -47.463% |
| Cellectis S.A. | -92.63 Million USD | 7634.249% |